Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03089749 · ClinicalTrials.gov registry record

Characterization of Human Autoantibody Titers After Central Nervous System Insult

A clinical trial, sponsored by University of Utah.

Terminated
Registry status
63
Enrollment target

NCT03089749 is a clinical trial that was terminated before completion, run by University of Utah. The registered enrollment target is 63 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03089749 was terminated before completion, sponsored by University of Utah.

TERMINATED
Registry status
63 participants
Enrollment target

Study Summary

The aim of the study is to quantitate Central Nervous System (CNS) autoantibody development in human blood using ELISA after human brain injury, spinal cord injury, and intra-axial brain surgeries.

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2015-05
Est. Completion 2019-05-20

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT03089749

The ClinicalTrials.gov registry entry for NCT03089749 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03089749 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03089749 about?

NCT03089749 is a clinical study titled "Characterization of Human Autoantibody Titers After Central Nervous System Insult". The aim of the study is to quantitate Central Nervous System (CNS) autoantibody development in human blood using ELISA after human brain injury, spinal cord injury, and intra-axial brain surgeries.

What is the current status of trial NCT03089749?

This trial is currently terminated. The enrollment target is 63 participants. The study started on 2015-05. Estimated completion is 2019-05-20.

Who is sponsoring clinical trial NCT03089749?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.